Nostrum Laboratories recalls
Nostrum Laboratories has 8 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 6 Aug 2025. 5 are still ongoing. The most frequent reason is nitrosamine impurity.
Total recalls8since 2016
Last 12 months0reported
Class I00% of total
Ongoing5latest 6 Aug 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 7 88%Class III 1 13%
Why nostrum laboratories is recalled
Product types
By year
Ongoing nostrum laboratories recalls
5 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Sucralfate Tablets recalled by Nostrum Laboratories | Nostrum Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg recalled | Nostrum Laboratories | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg recalled | Nostrum Laboratories | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg recalled | Nostrum Laboratories | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP 500 mg recalled | Nostrum Laboratories | Nitrosamine Impurity | Nationwide |
All nostrum laboratories recalls, newest first
8 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.